Clinical Trial Update: Induction Therapy for Patients With FLT3 Mutated Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial of induction therapy for FLT3-mutated acute myeloid leukemia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Guenther Koehne | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: WITHDRAWN